Tag: Lawsuit

  • Doctor Faces Lawsuit Alleging He Caused Opioid Addiction

    Doctor Faces Lawsuit Alleging He Caused Opioid Addiction

    A Pennsylvania physician is being sued for allegedly prescribing opioids in a reckless way that triggered a previous patient’s dependancy, in accordance to a civil lawsuit submitted before this month.

    The health practitioner, Ajeeb John Titus, MD, has been accused by former affected individual Carl Graves of prescribing at least 7,400 oxycodone tablets and 1,700 amphetamine products involving 2016 and 2020, without ordering any diagnostic testing or attempting alternate treatment method choices, in accordance to the lawful submitting. Graves claims that Titus’ prescribing methods led specifically to a intense opioid dependancy.

    Graves, who is joined in the lawsuit by his spouse, Sandi Jo, promises he was hospitalized quite a few situations right after receiving his last prescription from Titus on Sept. 21, 2020 — soon in advance of the physician was charged with various felony counts above alleged unlawful prescribing — and that he continued to involve professional medical treatment for his dependancy to the opioids prescribed by Titus, according to the lawful submitting.

    In the courtroom document, Graves statements that Titus “acted wantonly, recklessly and negligently by prescribing intense quantities and combinations of unsafe and addictive narcotic medicines with out healthcare justification.”

    The filing also notes that Titus failed to recognize the symptoms and signs of addiction, unsuccessful to wean Graves from the “deadly narcotic drugs” when he “knew or really should have recognised of the severe hazard of damage that would result,” and that Titus was “exclusively and exclusively” liable for the dependancy. As these kinds of, Graves and his spouse are demanding at minimum $100,000 in damages.

    According to a report by Lehigh Valley Live information, Titus was arraigned in September 2020 on 21 counts of unlawful administration of a controlled material, 4 counts of dispensing a controlled compound to a drug-dependent particular person, three counts of drug possession with intent to deliver, and a person counts of drug possession and drug possession by misrepresentation. The report also pointed out that he was produced on bail shortly afterward.

    The expenses have been similar to the very same opioid prescribing techniques named in the Graves lawsuit, but provided a 10-year time period, from January 2010 to January 2020, that associated a number of anonymous sufferers. Graves is not especially named in people prices.

    Titus was billed simply because he recommended controlled substances — this sort of as oxycontin, oxycodone and fentanyl — “exterior his authorized and moral apply of medicine,” in accordance to a 2020 press release from Pennsylvania Condition Attorney Typical Josh Shapiro.

    The push launch also said that Titus experienced failed to continue to keep accurate health-related information that would have supported the superior quantity of prescriptions for controlled substances, failed to carry out regime exams on his individuals, and charged that Titus would only question sufferers what types of medicines they preferred to be prescribed.

    “Titus was dependable by his neighborhood to diligently and thoughtfully create prescriptions in his patients’ best interests,” Shapiro reported in the 2020 press release. “Alternatively, he made use of his entry to prescribe remarkably addictive medications that are fueling the opioid crisis in Pennsylvania, and for his personal acquire.”

    • author['full_name']

      Michael DePeau-Wilson is a reporter on MedPage Today’s company & investigative team. He covers psychiatry, lengthy covid, and infectious illnesses, among other applicable U.S. medical information. Comply with

  • Court Dismisses Lawsuit of CBD User Who Tested Positive For Marijuana | Jackson Lewis P.C.

    Court Dismisses Lawsuit of CBD User Who Tested Positive For Marijuana | Jackson Lewis P.C.

    A federal court docket in Pennsylvania dismissed the legal claims asserted by a former worker who analyzed optimistic for cannabis on a random drug test and who attributed the take a look at consequence to CBD use.  Lehenky v. Toshiba America Power Programs Company, No. 20-cv-4573 (E.D. PA. February 22, 2022).

    The personnel alleged that in 2018, she was identified with an inflammatory autoimmune connective tissue disease.  She began working with a CBD products following listening to about its effectiveness. She in no way documented her medical problem, or the use of the CBD solution, to her employer.  The employer’s drug and alcoholic beverages policy needed personnel to report the use of medications that could be considered “illegal” prior to staying drug examined.  In January 2019, the employee was chosen for a random drug take a look at below the employer’s drug tests coverage that experienced been in effect given that at least 2016. One particular working day after taking the drug check, the employee delivered a letter from her physician that stated only that she was addressed with CBD which “may have a small stage of THC.”  THC is the psychoactive substance in cannabis which can cause a beneficial drug check end result.

    The staff tested good for marijuana and her work was terminated pursuant to the employer’s plan.  The worker asserted statements of disability discrimination under the Americans with Disabilities Act and the Pennsylvania Human Relations Act.

    The courtroom dismissed the employee’s statements for a amount of good reasons including that the employer did not know the personnel was disabled, the personnel was not certified for her situation thanks to the illegal drug use, and there had been no facts exhibiting that the employer “regarded” the worker as an unlawful drug user.  The courtroom also held that the drug tests coverage did not impose a disparate impression on experienced persons with disabilities.  Eventually, the courtroom held that a drug test to detect the unlawful use of medication did not constitute an impermissible healthcare inquiry.

    This circumstance highlights the actuality that the use of CBD merchandise can bring about positive drug examination results for cannabis.  While CBD solutions are marketed and bought everywhere, they are not still regulated by the U.S. Food stuff and Drug Administration.  These solutions may perhaps declare to have no THC in them or minimal degrees of THC in them, which may possibly or may not be real.  Even at minimal degrees, prolonged use of these solutions can lead to favourable marijuana take a look at benefits.

    Some states have legal guidelines permitting the clinical use of CBD goods for particular health care situations.  Businesses must check with with counsel to ensure their drug and alcohol guidelines tackle the use of CBD goods correctly beneath applicable laws.